Efficacy and safety of postoperative adjuvant chemotherapy with oxaliplatin for elderly patients: results from the CCOG-1302 study
Oxaliplatin combination chemotherapy can be safely administered to elderly patients. In addition, intermittent administration may be more useful in elderly individuals for the prevention of PSN.
Authors
- Yasuhiro Kodera (ORCID: https://orcid.org/0000-0002-6173-7474)
- Mitsuro Kanda (ORCID: https://orcid.org/0000-0001-5464-3819)
- Norifumi Hattori (ORCID: https://orcid.org/0000-0002-1433-7208)
- Takayoshi Kishida
- Haruyoshi Tanaka (ORCID: https://orcid.org/0000-0003-0079-8422)
- Koki Nakanishi (ORCID: https://orcid.org/0000-0002-0629-798X)
- Masamichi Hayashi (ORCID: https://orcid.org/0000-0001-6875-2303)
- Chie Tanaka (ORCID: https://orcid.org/0000-0002-7931-8753)
- Dai Shimizu (ORCID: https://orcid.org/0000-0002-7565-6640)
- Hideki Takami (ORCID: https://orcid.org/0009-0004-3294-0168)
- Shinichi Umeda
- Goro Nakayama
Institutions
- Nagoya University (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1007/s10147-025-02738-w
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nagoya University